Santosh K Maurya

About

My research is in Cancer Cell Biology and current project is 'Targeting of cancer cells and cancer stem cells by naturally occurring Phytochemicals.

Employment

• Hebrew University of Jerusalem Post Doctoral Fellow
  2025 - Present
• Weizmann Institute of Science Researcher
  2025 - 2025
• Central University of Punjab Project Research Scientist-I (non-Medical)
  2023 - 2026
• Aligarh Muslim University Junior Research Fellow
  2019 - 2021
• Central University of Punjab Junior Research Fellow
  2017 - 2018

Education

• Central University of Punjab Ph.D.
  2021 - Present
• University of Allahabad M.Sc.
  2015 - 2017
• Satish Chandra PG College B.Sc.
  2012 - 2015

Projects & Funding

Projects & funding information is unavailable.

Publications (16)

• Combination of Simvastatin and Metformin Reduces Triple‐Negative Breast Cancer Tumor Growth Through AKT/AMPK/ACC Signaling Axis
  Molecular Carcinogenesis 2025 DOI: 10.1002/mc.70056
  +Save
• Repurposing of Metabolic Drugs Metformin and Simvastatin as an Emerging Class of Cancer Therapeutics
  Pharmaceutical Research 2025 DOI: 10.1007/s11095-024-03811-1
  +Save
• Lupeol, an androgen receptor inhibitor, enhances the chemosensitivity of prostate cancer stem cells to antiandrogen enzalutamide-based therapy
  Toxicology and Applied Pharmacology 2023
  +Save
• Repurposing FDA-approved anti-diabetic drug to target H. pylori peptidyl deformylase using computer-based drug discovery approach
  Molecular Simulation 2022 DOI: 10.1080/08927022.2022.2130377
  +Save
• Role of lupeol in chemosensitizing therapy-resistant prostate cancer cells by targeting MYC, β-catenin and c-FLIP: in silico and in vitro studies
  In Silico Pharmacology 2022 DOI: 10.1007/s40203-022-00131-3
  +Save
• Withania somnifera phytochemicals possess SARS-CoV-2 RdRp and human TMPRSS2 protein binding potential
  Vegetos 2022 DOI: 10.1007/s42535-022-00404-4
  +Save
• Antiandrogen enzalutamide induced genetic, cellular, and hepatic damages: amelioration by triterpene Lupeol.
  Drug and chemical toxicology 2022 DOI: 10.1080/01480545.2022.2040528
  +Save
• The Multiple Faces of NANOG in Cancer: A Therapeutic Target to Chemosensitize Therapy-Resistant Cancers
  Epigenomics 2021 DOI: 10.2217/epi-2021-0228
  +Save
• Abstract 276: Lupeol chemosensitize the cancer stem cells for enzalutamide and ameliorate the enzalutamide induced toxicity in prostate cancer
  Proceedings: AACR Annual Meeting 2021; April 10-15, 2021 and May 17-21, 2021; Philadelphia, PA 2021 DOI: 10.1158/1538-7445.am2021-276
  +Save
• Mechanochemical Synthesis of Sulfur Quantum Dots for Cellular Imaging
  ACS Applied Nano Materials 2021
  +Save